
Orchid
Genetic testing solutions for personalized health risk assessment and family planning.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor investor investor investor investor investor | €0.0 | round |
investor investor | €0.0 | round | |
investor | €0.0 | round | |
* | $12.0m | Early VC | |
Total Funding | 000k |
Related Content
Orchid Health is a cutting-edge startup that specializes in genetic testing and health optimization. The company provides a range of genetic tests that help individuals understand their risk for various diseases, including heart disease, diabetes, cancer, and neurodevelopmental disorders. Orchid Health serves a diverse clientele, including individuals looking to optimize their health, couples planning for pregnancy, and patients with a family history of genetic conditions.
Operating in the rapidly growing genetic testing market, Orchid Health leverages advanced genomic technologies to offer personalized health insights. The company’s business model is primarily direct-to-consumer, meaning they sell their genetic testing services directly to individuals through their website. Additionally, they collaborate with healthcare providers to integrate genetic testing into routine medical care.
Orchid Health makes money by selling genetic testing kits and offering subscription-based services for ongoing health monitoring and personalized health recommendations. They also provide expert-reviewed guides and resources to help clients understand their genetic risks and make informed health decisions.
In summary, Orchid Health is at the forefront of personalized medicine, offering genetic testing services that empower individuals to take control of their health and make proactive decisions.
Keywords: genetic testing, health optimization, personalized medicine, disease risk, fertility, pregnancy planning, direct-to-consumer, genomic technology, health monitoring, healthcare integration.